CareDx CDNA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -3.9%+4.2pp | -8.1%-24.8pp | 16.7%+3.1pp | 13.5%-0.9pp | 14.4%+2.2pp | |
| Net margin | -2%+3.6pp | -5.6%-25.3pp | 19.7%+2.6pp | 17.1%-0.9pp | 17.9%+2.2pp | |
| Returns | ||||||
| Return on equity | -2.4%+3.9pp | -6.3%-30.4pp | 24.1%+4.5pp | 19.6%+0.1pp | 19.5%+3.1pp | |
| Return on invested capital | -5.6%+5.5pp | -11.1%-37.3pp | 26.2%+7.4pp | 18.8%-0.4pp | 19.2%+3.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×+0.1× | 0.8×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.4×+0.5× | 2.9×-0.2× | 3×-0.3× | 3.3×-0.8× | 4.1×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $5.90+3.8% | $5.69-1.8% | $5.79-4.0% | $6.03-12.2% | $6.86+2.7% | |
| Valuation | ||||||
| Market capitalization | $1.4B+32.2% | $968.99M+25.2% | $773.92M-26.4% | $1.05B+6.9% | $983.81M-14.3% | |
| Price / sales | 3.4×+0.3× | 2.6×+0.4× | 2.2×-0.9× | 3.1×+0.2× | 2.8×-0.6× | |
| Price / book | 4.5×+1.7× | 3.2×+0.7× | 2.5×-0.7× | 3.2×+0.6× | 2.6×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CareDx's profit margins?
- CareDx (CDNA) runs a 65.5% gross margin and a -3.9% operating margin, with a -2.0% net margin.
- Where do CareDx's ratios come from?
- Every ratio is computed from CareDx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
